Zobrazeno 91 - 100
of 285
pro vyhledávání: '"Cara Haymaker"'
Autor:
Patrick Hwu, Scott E. Woodman, Gregory Lizée, Jason Roszik, Weiyi Peng, Anil Korkut, Rodabe N. Amaria, Timothy Heffernan, Chantale Bernatchez, Michael A. Davies, Jennifer A. Wargo, Roger S. Lo, Richard Eric Davis, Zhi-Qiang Wang, Rina M. Mbofung, Zhe Wang, Leila J. Williams, Marie-Andrée Forget, Cara Haymaker, Tatiana Karpinets, Trang Tieu, Amjad H. Talukder, Miles C. Andrews, Jodi A. McKenzie, Shruti Malu, Lu Huang
Supplementary figure and table legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5abd5f1d309bef3964bb51693f7a8cf7
https://doi.org/10.1158/1078-0432.22464123
https://doi.org/10.1158/1078-0432.22464123
Autor:
Caitlin A. Creasy, Yuzhong Jeff Meng, Marie-Andrée Forget, Tatiana Karpinets, Katarzyna Tomczak, Chip Stewart, Carlos A. Torres-Cabala, Shari Pilon-Thomas, Amod A. Sarnaik, James J. Mulé, Levi Garraway, Matias Bustos, Jianhua Zhang, Sapna P. Patel, Adi Diab, Isabella C. Glitza, Cassian Yee, Hussein Tawbi, Michael K. Wong, Jennifer McQuade, Dave S.B. Hoon, Michael A. Davies, Patrick Hwu, Rodabe N. Amaria, Cara Haymaker, Rameen Beroukhim, Chantale Bernatchez
Publikováno v:
Clin Cancer Res
Purpose:Adoptive cell therapy (ACT) of tumor-infiltrating lymphocytes (TIL) historically yields a 40%–50% response rate in metastatic melanoma. However, the determinants of outcome are largely unknown.Experimental Design:We investigated tumor-based
Autor:
June Li, Karen Millerchip, Carlos Ramos, Edwin Parra, Luisa Solis, Alex Stevenson, Aurelie Couturier, Gayle Fyvie, Michael Chisamore, Rahul Parikh, Eric Bernicker, Diwakar Davar, Arvind Chaudhry, Nizar Tannir, Shubham Pant, Cara Haymaker
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Jacqueline Oliva, Younghee Lee, Rebeca Rodriguez, Katarzyna Tomczak, Davis Ingram, Xiao Zhou, Vinod Ravi, Anthony Conley, John Livingston, Joseph Ludwig, Neeta Somaiah, Cara Haymaker
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Salah-Eddine Bentebibel, Daniel Johnson, Barbara Pazdrak, Daniel McGrail, Srisuda Lecagoonporn, Cara Haymaker, Dzifa Y Duose, Khalida Wani, Heather Sonnemann, Houssein Safa, Jared K Burks, Patrick Hwu, cho Sungnam, Chantale Bernatchez, Suhendan Ekmekcioglu, Gregory Lizée, Adi Diab
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Aung Naing, Sara Ferrando-Martinez, Michael Ware, Cara Haymaker, Allison Bierly, Jack Goon, Marya Chaney, Swati Dhar, Chan-Young Ock, Siyoung Lee, Kyunghyun Paeng, Taeseob Lee, Tolani Adebanjo, Se Hwan Yang, Byung Ha Lee, Richard Kim
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Katarzyna Tomczak, Carlos Ramos, Nathaniel Deboever, Nicolas Zhou, Jacqueline Liszeth Oliva, Chang-Jiun Wu, Chad Strange, Annikka Weissferdt, David Rice, Reza Mehran, Jianjun Zhang, Mehmet Altan, Anne Tsao, Boris Sepesi, Cara Haymaker
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Dante Bortone, Anne Monette, Nicholas Tschernia, Alexandria Cogdill, Yana Najjar, Randy F Sweis, Sara Valpione, Erik Wennerberg, Praveen Bommareddy, Cara Haymaker, Uqba Khan, Heather M McGee, Wungki Park, Houssein A Sater, Christine Spencer, Maria Ascierto, Valentin Barsan, Vinita Popat, Daniel Wells, Steven Vensko, Sarah Dexheimer, Vesteinn Thorsson, Roberta Zappasodi, Nils-Petter Rudqvist, Benjamin Vincent
Publikováno v:
Regular and Young Investigator Award Abstracts.
Publikováno v:
Cancer Immunology Research. 9:1252-1261
Engineering immune cells to target cancer is a rapidly advancing technology. The first commercial products, chimeric-antigen receptor (CAR) T cells, are now approved for hematologic malignancies. However, solid tumors pose a greater challenge for cel
Autor:
Bret M. Stephens, Maria E. Monberg, Vincent Bernard, Kimal I. Rajapakshe, Manoop S. Bhutani, Chantale Bernatchez, Jaewon J. Lee, Daniel Lin, Cullen M. Taniguchi, Jonathan Huang, Cara Haymaker, Alexander Semaan, Brian Weston, Paola A. Guerrero, Anirban Maitra
Publikováno v:
Clin Cancer Res
Purpose: Precision medicine approaches in pancreatic ductal adenocarcinoma (PDAC) are imperative for improving disease outcomes. With molecular subtypes of PDAC gaining relevance in the context of therapeutic stratification, the ability to characteri